- World Health Organization held a media briefing on Africa Day, 25 May, to update the public on the COVID-19 coronavirus pandemic.
- Clinical trial of hydroxycholoroquine suspended after Lancet study finds drug causes ‘higher mortality rate’ among COVID-19 patients.
- The risk of death increased by 34% and the risk of hearth arrythmimas increased by 137%.
- Lower number of cases in sub-Saharian Africa attributed to Ebola experience and speedy response by African Union.
- Leaders were urged to ensure testing and tracing.
Africa ‘least affected’ by COVID-19; hydroxycholoroquine trial suspended – WHO briefing
(05/25/2020)
